TRIB
Trinity Biotech Plc - Acquires Epicapture for $3 Million Plus $0.5 Million Contingent
时间：2024-10-25 20:45:00 市场： 美股 综合
Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform
时间：2024-10-25 20:45:00 市场： 美股 综合
Trinity Biotech Enters Oncology Space With Acquisition of Prostate Cancer Focused Epicapture
时间：2024-10-25 20:45:00 市场： 美股 综合
Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market
时间：2024-09-25 04:05:00 市场： 美股 综合
Trinity Biotech to Initiate Cgm Market Study in India in Furtherance of Intended Collaboration With Bayer
时间：2024-09-19 04:05:07 市场： 美股 综合
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Poised to End Week Higher European equities traded in the US as American depositary receipts were moving higher late Friday morning, rising 0.82% to 1,443.36 on the S&P Europe Select ADR Index. The gain is helping the index end the week 1.2% higher.From continental Europe, the gainers were led by biotech firm BioNTech (BNTX) and biopharmaceutical firm Genfit (GNFT), which climbed 13% and 4.7%, respectively. They were followed by biotech firm Evaxion Biotech (EVAX) and pharmaceutical firm Ascendis Pharma (ASND), which increased 3.4% and 2.7%, respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and accommodations booking site trivago (TRVG), which fell 2.1% and 1.1%, respectively. They were followed by telecommunications company VEON (VEON) and medical device maker EDAP TMS (EDAP), which were off 0.8% and 0.5%, respectively.From the UK and Irela
时间：2024-09-13 23:19:01 市场： 美股 综合